San Francisco, California, United States
Candidates should possess a Bachelor's degree in a science or medical-related field with at least 15 years of industry experience, a Master's degree with 13 years of experience, or a PhD with 10 years of experience. Experience with common regulatory documents such as CSRs, IBs, DSURs, protocols, and clinical modules is required, along with an expert understanding of eCTD structure, the clinical development process, and document-related ICH guidelines and GxPs. Involvement with marketing applications (INDs, BLAs, NDAs, MAAs, or equivalents) is preferred, and at least 8 years of experience as a writer in biotechnology or an equivalent field is necessary. Applicants must be authorized to work in the U.S. without sponsorship.
The Director, Regulatory Writing will craft clear, accurate, and compliant documents for global health authority submissions, including protocols, Investigator Brochures, Clinical Study Reports, briefing packages, and regulatory submission dossiers. They will ensure all documentation adheres to relevant regulatory guidelines and standards, such as ICH E3 and ICH M4. Responsibilities include analyzing complex scientific and medical information, translating it into understandable language, and collaborating with cross-functional teams to gather data and ensure comprehensive documentation. The role also involves managing writing projects from planning to submission, including establishing timelines and tracking progress.
Develops monoclonal antibodies for infectious diseases
Vir Biotechnology develops treatments that leverage the immune system to combat infectious diseases. The company uses a proprietary monoclonal antibody platform combined with machine learning to create a database of human antibodies, which aids in developing effective medicines. Their pipeline includes candidates for hepatitis B, hepatitis delta, HIV, and various viruses like influenza and COVID-19. Vir stands out by collaborating with industry leaders and organizations to accelerate scientific advancements, with the goal of transforming lives through innovative therapies.